WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Yvette Fielding says her Most Haunted co
Xinhua Commentary: Xi's Meeting with Ma Injects Positive Energy to Relations Across Taiwan Strait
Final touches put on Asian Games prep
Does the U.S. See Pacific Island Countries As True Partners?
What's next for Iran after death of its president in crash?
GT Voice: US Treasury yield signals economy in ‘vicious cycle’
Chinese pianist Lang Lang honored with Hollywood Walk of Fame star
Commentary: Working together for enduring China
Jon Wysocki dead at 53: Staind drummer passes away
Xi Focus: Xi Jinping Meets Ma Ying
Six killed in a 'foiled coup' in Congo, the army says
To jointly write new stories of friendship between Chinese, American people in new era